Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for P53607

Entry ID Method Resolution Chain Position Source
AF-P53607-F1 Predicted AlphaFoldDB

No variants for P53607

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for P53607

No associated diseases with P53607

4 regional properties for P53607

Type Name Position InterPro Accession
binding_site Serine/threonine dehydratase, pyridoxal-phosphate-binding site 43 - 56 IPR000634
domain Threonine dehydratase, ACT-like domain 323 - 412 IPR001721-1
domain Threonine dehydratase, ACT-like domain 424 - 506 IPR001721-2
domain Tryptophan synthase beta chain-like, PALP domain 18 - 310 IPR001926

Functions

Description
EC Number 4.3.1.19 Ammonia-lyases
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

2 GO annotations of molecular function

Name Definition
L-threonine ammonia-lyase activity Catalysis of the reaction: L-threonine = 2-oxobutanoate + NH3.
pyridoxal phosphate binding Binding to pyridoxal 5' phosphate, 3-hydroxy-5-(hydroxymethyl)-2-methyl4-pyridine carboxaldehyde 5' phosphate, the biologically active form of vitamin B6.

2 GO annotations of biological process

Name Definition
isoleucine biosynthetic process The chemical reactions and pathways resulting in the formation of isoleucine, (2R*,3R*)-2-amino-3-methylpentanoic acid.
threonine metabolic process The chemical reactions and pathways involving threonine (2-amino-3-hydroxybutyric acid), a polar, uncharged, essential amino acid found in peptide linkage in proteins.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MASHDYLKKI LTARVYDVAF ETELEPARNL SARLRNPVYL KREDNQPVFS FKLRGAYNKM
70 80 90 100 110 120
AHIPADALAR GVITASAGNH AQGVAFSAAR MGVKAVIVVP VTTPQVKVDA VRAHGGPGVE
130 140 150 160 170 180
VIQAGESYSD AYAHALKVQE ERGLTFVHPF DDPYVIAGQG TIAMEILRQH QGPIHAIFVP
190 200 210 220 230 240
IGGGGLAAGV AAYVKAVRPE IKVIGVQAED SCAMAQSLQA GKRVELAEVG LFADGTAVKL
250 260 270 280 290 300
VGEETFRLCK EYLDGVVTVD TDALCAAIKD VFQDTRSVLE PSGALAVAGA KLYAEREGIE
310 320 330 340 350 360
NQTLVAVTSG ANMNFDRMRF VAERAEVGEA REAVFAVTIP EERGSFKRFC SLVGDRNVTE
370 380 390 400 410 420
FNYRIADAQS AHIFVGVQIR RRGESADIAA NFESHGFKTA DLTHDELSKE HIRYMVGGRS
430 440 450 460 470 480
PLALDERLFR FEFPERPGAL MKFLSSMAPD WNISLFHYRN QGADYSSILV GLQVPQADHA
490 500
EFERFLAALG YPYVEESANP AYRLFLS